Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

RENAL TREATMENT CENTERS SOUTHEAST LP

NPI: 1376950345 · HOUSTON, TX 77091 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/22/2014

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more

$0.00
Total Medicaid Paid
1,963
Total Claims
602
Beneficiaries
11
Codes Billed
2021-01
First Month
2021-07
Last Month

Provider Details

Authorized OfficialWINSTEL, JOHN (CHIEF ACCOUNTING OFFICER)
NPI Enumeration Date07/22/2014

Related Entities

Other providers sharing the same authorized official: WINSTEL, JOHN

ProviderCityStateTotal Paid
TOTAL RENAL CARE INC INGLEWOOD CA $22.54M
TOTAL RENAL CARE INC MIAMI FL $16.77M
DVA HEALTHCARE RENAL CARE INC LOS ANGELES CA $14.01M
DVA HEALTHCARE RENAL CARE INC BURBANK CA $10.72M
DVA HEALTHCARE RENAL CARE INC OAKLAND CA $10.67M
DVA HEALTHCARE RENAL CARE INC WESTMINSTER CA $8.32M
DVA HEALTHCARE RENAL CARE INC APPLE VALLEY CA $6.93M
DVA HEALTHCARE RENAL CARE INC GLENDALE CA $5.32M
RENAL TREATMENT CENTERS CALIFORNIA INC SANTA ANA CA $5.08M
DVA HEALTHCARE RENAL CARE INC BERKELEY CA $4.25M
TOTAL RENAL CARE INC PLANTATION FL $4.08M
DVA RENAL HEALTHCARE INC LOS ANGELES CA $4.01M
DVA HEALTHCARE OF MASSACHUSETTS INC SALEM MA $3.57M
DVA RENAL HEALTHCARE INC SIERRA VISTA AZ $3.52M
RENAL TREATMENT CENTERS-SOUTHEAST, LP. PANAMA CITY FL $3.14M
WESTON DIALYSIS CENTER LLC WESTON FL $3.01M
BEVERLY HILLS DIALYSIS PARTNERSHIP BEVERLY HILLS CA $2.90M
RENAL TREATMENT CENTERS CALIFORNIA INC EL MONTE CA $2.82M
TOTAL RENAL CARE INC ANTIOCH CA $2.72M
DVA HEALTHCARE RENAL CARE INC PHILADELPHIA PA $2.30M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2021 1,963 $0.00

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
A4657 Syringe, with or without needle, each 101 101 $0.00
Q4081 Injection, epoetin alfa, 100 units (for esrd on dialysis) 1,412 88 $0.00
G0499 Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result 52 30 $0.00
82746 28 28 $0.00
83550 29 29 $0.00
82728 30 30 $0.00
85048 86 83 $0.00
83540 29 29 $0.00
85041 86 83 $0.00
83970 33 33 $0.00
85045 77 68 $0.00